Skip to main content

Andres Francisco Pacheco Reyes

Institutions of which they are part

Predoctoral researcher
Shock, Organ Dysfunction and Resuscitation
Vall Hebron Institut de Recerca

Andres Francisco Pacheco Reyes

Institutions of which they are part

Predoctoral researcher
Shock, Organ Dysfunction and Resuscitation
Vall Hebron Institut de Recerca

Research lines

Acute respiratory failure

The line of research in acute respiratory failure has special interest in the study of the involvement of the interleukin 33 and its ST2 receptor in acute lung injury and its role as a possible therapeutic target. A model of acute lung injury in mice has been designed to show the prognostic efficacy of interleukin 33 and ST-2 plasma levels. Currently, SODIR is evaluating the possibility that treatment with anti-IL-33 antibodies may decrease the degree of inflammation in a murine experimental model of acute lung injury.

Another issue of special interest is the use of high flow nasal cannula supportive therapy. In this sense, SODIR has participated in a multicentric study, recently published in JAMA, analyzing the effect of high flow nasal cannula on postextubation respiratory failure.

Finally, SODIR is also involved in several multicentric international trials about the use of esophageal pressure to guide mechanical ventilation settings in patients with acute respiratory distress syndrome.

IP: Andres Francisco Pacheco Reyes

Projects

Validación clínica de Heecap, un sistema de electroestimulación no invasiva de la musculatura respiratoria para pacientes bajo ventilación mecánica.

IP: Ricard Ferrer Roca
Collaborators: Andres Francisco Pacheco Reyes, Alba Gómez Garrido, Francisco Javier Ramos Gómez, Gonzalo Ballesteros Reviriego
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 221996
Reference: CPP2023-010467
Duration: 01/05/2024 - 30/04/2027

Ministerio de Ciencia

Diseño de estación de trabajo para soporte a la toma de decisiones en el paciente crítico con ventilación mecánica invasiva (WS-VENT).

IP: -
Collaborators: Ricard Ferrer Roca, Andres Francisco Pacheco Reyes, Ricard Ferrer Roca, Ricard Ferrer Roca, Ricard Ferrer Roca, Ricard Ferrer Roca, Ricard Ferrer Roca, Ricard Ferrer Roca, Ricard Ferrer Roca, Ricard Ferrer Roca, Andres Francisco Pacheco Reyes
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 42205
Reference: CPP2021-008340
Duration: 01/09/2022 - 31/08/2025

Ministerio de Ciencia

Related news

The study will be conducted in the Intensive Care Medicine Service of the Vall d’Hebron University Hospital and will validate the prognostic value of the NLRP3 biomarker.

SOFA-2 is being updated after thirty years to incorporate advances in diagnosis, monitoring and life support.

On European Antibiotic Awareness Day, we highlight the importance of using these medications responsibly and finding innovative solutions to combat this issue.

Related professionals

Maria Luz Uría Oficialdegui

Maria Luz Uría Oficialdegui

Predoctoral researcher
Childhood Cancer and Blood Disorders
Read more
Oscar José Hernández Cristancho

Oscar José Hernández Cristancho

Predoctoral researcher
Physiology and Pathophysiology of the Digestive Tract
Read more
Eva Llarch Pinell

Eva Llarch Pinell

Main researcher
Research on Aging, Frailty and Transitions in Barcelona
Read more
Marta Kinga Klimczak

Marta Kinga Klimczak

Predoctoral researcher
Neurovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.